PLJR965 Citations (2)

Originally described in: Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platform.
Rock JM, Hopkins FF, Chavez A, Diallo M, Chase MR, Gerrick ER, Pritchard JR, Church GM, Rubin EJ, Sassetti CM, Schnappinger D, Fortune SM Nat Microbiol. 2017 Feb 6;2:16274. doi: 10.1038/nmicrobiol.2016.274. PubMed Journal

---

Articles Citing PLJR965

Articles
Human Kinase IGF1R/IR Inhibitor Linsitinib Controls the In Vitro and Intracellular Growth of Mycobacterium tuberculosis. Wang H, Bi J, Zhang Y, Pan M, Guo Q, Xiao G, Cui Y, Hu S, Chan CK, Yuan Y, Kaneko T, Zhang G, Chen S. ACS Infect Dis. 2022 Oct 14;8(10):2019-2027. doi: 10.1021/acsinfecdis.2c00278. Epub 2022 Sep 1. PubMed
PatA Regulates Isoniazid Resistance by Mediating Mycolic Acid Synthesis and Controls Biofilm Formation by Affecting Lipid Synthesis in Mycobacteria. Wang K, Deng Y, Cui X, Chen M, Ou Y, Li D, Guo M, Li W. Microbiol Spectr. 2023 Jun 15;11(3):e0092823. doi: 10.1128/spectrum.00928-23. Epub 2023 May 22. PubMed

If you have published an article using this material, please email us at to have your article added to this page.